Adaptive Biotechnologies Corporation - notizie pubblicate 188 - letture 6.349
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Statement of Changes in Beneficial Ownership - Form 4
Form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchange commission washingt ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Adaptive Biotechnologies to Participate in the 43rd Annual Cowen Healthcare Conference
Pdf version seattle, feb. 27, 2023 (globe newswire) -- adaptive biotechnologies corporation ("adaptive biotechnologies") (nasdaq: adpt), a commercial stage biotechnology ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Initial Registration Statement for Employee Benefit Plan - Form S-8
S-8 as filed with the securities and exchange commission on february 14, 2023 registration no. 333- united states securities and exchange commission washington, d.c. 20549 form s-8 ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Annual Report for Fiscal Year Ending December 31, 2022 (Form 10-K)
10-k united states securities and exchange commission washington, dc 20549 form 10-k (mark one) ☒ annual report pursuant to section 13 or 15(d) of the securities exchange act of ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2022 Financial Results - Form 8-K
Adaptive biotechnologies reports fourth quarter and full year 2022 financial results seattle, feb. 14, 2023 (globe newswire) - adaptive biotechnologies corporation ("adaptive ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Adaptive Biotechnologies Q4 2022 Earnings Presentation
Fourth quarter and fy 2022 earnings conference call safe harbor this presentation has been prepared by adaptive biotechnologies corporation ("we," "us," "o ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2022 Financial Results
Pdf version seattle, feb. 14, 2023 (globe newswire) -- adaptive biotechnologies corporation ("adaptive biotechnologies") (nasdaq: adpt), a commercial stage biotechnology ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2022 Financial Results on February 14, 2023
Pdf version seattle, jan. 23, 2023 (globe newswire) -- adaptive biotechnologies corporation ("adaptive biotechnologies") (nasdaq: adpt), a commercial stage biotechnology ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Adaptive Biotechnologies to Present at the 41st Annual J.P. Morgan Healthcare Conference
Pdf version seattle, dec. 27, 2022 (globe newswire) -- adaptive biotechnologies corporation ("adaptive biotechnologies") (nasdaq: adpt), a commercial stage biotechnology ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Adaptive Biotechnologies Highlights New Data Showcasing the Clinical Utility of clonoSEQ® MRD Testing in Patients with Blood Cancers at the 64th ASH Annual Meeting
Pdf version multiple presentations reinforce clonoseq's ability to provide valuable insights for treatment surveillance and clinical decision-making more than 30 clonoseq-related a ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Adaptive Biotechnologies Announces Launch of clonoSEQ® to Assess Minimal Residual Disease (MRD) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Using Circulating Tumor DNA (ctDNA)
Pdf version clonoseq is the first and only mrd test in dlbcl with medicare coverage across all lines of therapy, treatment regimens, and timepoints adaptive now accepts blood sampl ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Adaptive Biotechnologies to Participate in the Piper Sandler Healthcare Conference
Pdf version seattle, nov. 21, 2022 (globe newswire) -- adaptive biotechnologies corporation ("adaptive biotechnologies") (nasdaq: adpt), a commercial stage biotechnology ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
New Survey Reveals the Majority of Myeloma Patients That Undergo Minimal Residual Disease (MRD) Testing Find a Clear Clinical or Emotional Benefit from Results
Pdf version >95% of patients who had an mrd test describe that mrd testing helped inform treatment decisions or brought comfort in their treatment journey 85% of surveyed patien ...
Sei un professionista?
Abbiamo ricevuto 2.400 richieste di consulenza, pubblica il tuo profilo premium
per ricevere contatti e acquisire nuovi clienti